Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Onconano Medicine Inc.
Headquarters: Southlake, TX, United States of America
Website: https://www.onconanomed.com
Year Founded: 2012
Status: Private
BioCentury | Mar 1, 2024
Management Tracks
Jenne returns to Ionis
Plus: Krishnan to succeed CEO Driscoll at OncoNano and an update from Alvotech
BioCentury | Nov 7, 2023
Management Tracks
Krishnan promoted to president and head of R&D at OncoNano
Plus: McCourt becomes co-CEO of Hudson, and updates from MeMed, Enhance3D and Avalyn
BioCentury | Jun 2, 2022
Management Tracks
Anderson to lead Pfizer’s vaccine R&D
Plus CFO Luca Scavo resigns from Evelo, Passage Bio’s CEO steps down, and updates from MindMaze, Black Diamond and more
BioCentury | Feb 4, 2021
Management Tracks
Novo Foundation names Krogsgaard Thomsen CEO; plus Takeda’s Sequeira to become first woman to chair PhRMA and updates from Almirall, Twist, Oncosec and more
Biomedical research foundation Novo Nordisk Foundation named Mads Krogsgaard Thomsen, EVP and CSO at Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) as CEO, effective March 1. He replaces Birgitte
BioCentury | Feb 3, 2021
Management Tracks
Lilly Asia’s Li joins AffaMed as president; plus moves at Actimed, Elicio, Life Biosciences, OncoNano, Tollys, HighTide and Patient Square Capital
China-based in-licensing company AffaMed Therapeutics (Shanghai) Co. Ltd. hired Ji Li as president. Li was most recently a venture partner at Lilly Asia Ventures, and prior to that
BioCentury | Aug 27, 2019
Company News
Aug. 27 Company Quick Takes: GSK licenses Ionis HBV program; plus Adaptimmune-Noile, Purdue, Presage-BMS, Kyowa, Alexion, Viela, Kintai, OncoNano
Items per page:
1 - 6 of 6